Leading provider of high-quality, system-critical elastomer components
With recognized core competencies in solution design, material know-how and product industrialization, we are a strategic engineering partner for innovative systems in Healthcare, Transportation & Electronics, General Industry and Food & Beverage. Read more about us.
Softpulse
Boosting your wearable application to the next level with SoftPulse™
Soft dry electrodes can be used for easy, comfortable, and long-term monitoring of bio-signals like EEG, ECG, EMG and EOG for consumer as well as medical applications.
Prefilled Syringes
NeoFlex™ Plungers: Superior Drug Delivery Solutions
Datwyler’s NeoFlex™ Plungers: The Reliable Choice for Prefilled Syringes and Cartridges. Our premium plungers offer superior performance and compliance for self-administration devices, meeting the highest industry standards.
Electro Active Polymers (EAP)
Advanced manufacturing of a novel actuation technology
Actuators are mechanical components that allow the transformation of electrical energy into mechanical energy and enable a multipurpose and efficient operation.
Latest news
Datwyler has successfully completed the acquisition of a majority stake in Capsul’in as announced in December 2025.
In the 2025 financial year, Datwyler generated revenue of CHF 1’100.5 million. Adjusted for negative currency effects of -3.7%, the company achieved organic growth of 3.1%. Due to these currency effects, reported revenue was overall 0.6% below the prior-year level.
Datwyler has received validation of its short-term, Group-wide greenhouse gas reduction targets by the Science Based Targets initiative (SBTi).
The Swiss Datwyler site in Schattdorf, Switzerland, took 1st place in the Swiss Arbeitgeber Award 2026 in the category for large companies (250–999 employees).
Datwyler has signed an agreement to acquire 51% of Capsul’Invest SA und Brain Corp SA (together operating as Capsul’in), a leading provider of aluminum coffee capsule solutions headquartered in Luxembourg with annual revenues of approximately EUR 90 million.
Sustainability
Plan for solar panels at the Indian plant (2021)
Use of solar panels to generate electricity will help reduce intake from the public power grid. Supply of more than 2’100 MWh of electricity per year. Reduction of CO(sub:2) emission by some 1’800 tons per year. Second phase with solar panels on roof of new building (2022) will add another 2’500 MWh of electricitiy and reduce CO(sub:2)-emissions by another 2’200 tons.
Plan for solar panels at Datwyler plant in Kesurdi, India
Billions of syringes worldwide contain Datwyler components. We are global number two for Sealing Solutions for Parenteral Medicines & Medical Devices.
Living a customer-focused culture
Sustainability
Exhaust air purification system at Chinese plant
Exhaust air purification system at Datwyler plant in Ningguo, China
Continuous improving processes
We are dedicated to continuous improvement in all we do. Our quality management system is supported by digitalisation thus enabling analysis, exchange of knowledge, and standardisation. We use a risk-based approach and our expertise to meet the changing needs of our customers and other stakeholders and to shape future oriented processes.
Upcoming Events
China PFS and Precision Dosing Conference
Suzhou, China
